Ajanta Pharma BUYBACK 2020 | LATEST Ajanta Pharma SHARE NEWS | Ajanta Pharma BUY BACK RECORD DATE | Ajanta Pharma BUYBACK PRICE | Latest Buybacks News
The board of Ajanta Pharma on Tuesday approved a proposal to buyback ₹135.97 crore worth shares.
Accordingly the company plans to buyback 7.35 lakh shares (representing 0.84 per cent of the total paid-up share capital) at ₹1,850 a share.
The board has fixed November 13 as the record date for determining the eligible shareholders to participate in the buyback. Shares of Ajanta Pharma closed ₹1,609.95 on the BSE.
Ajanta Pharma Share Buyback Offer Details
Ajanta Pharma Share Buy Back Plan | Ajanta Pharma Buyback Shares
| Buyback Type: | Tender Offer |
| Ajanta Pharma Buyback Record Date: | Nov 13 2020 |
| Ajanta Pharma Buyback Offer Amount: | ₹ 135 |
| Date of Board Meeting approving the proposal: | Nov 03 2020 |
| Date of Public Announcement: | Nov 03 2020 |
| Ajanta Pharma Buyback Offer Size: | 0.84% |
| Buyback Number of Shares: | 7,35,000 |
| Price Type: | Tender Offer |
| Face Value (FV): | 2 |
| Ajanta Pharma Buyback Price: | ₹ 1850 Per Equity Share |
| Ajanta Pharma Buyback Premium: | 20% |
Can I Invest today to participate in Ajanta Pharma buyback offer? : Yes
The Board of Directors of Ajanta Pharma Ltd, at its meeting held on 3rd November 2020, have unanimously approved the proposal to buyback its fully paid-up equity shares of Rs. 2/- (Rupees Two only) each not exceeding 7,35,000 (Seven Lakhs Thirty-Five Thousand only) equity shares (representing 0.84% of the total number of equity shares in the paid-up share capital of the Company) at a price of Rs. 1,850/- (Rupees One Thousand Eight Hundred and Fifty only) per equity share.
Also Check:- Ajanta Pharma Dividend 2020
Ajanta Pharma Q2 Results
Ajanta Pharma Consolidated September 2020 Net Sales at Rs 715.91 crore, up 11.38% Y-o-Y.
Net Sales at Rs 715.91 crore in September 2020 up 11.38% from Rs. 642.76 crore in September 2019.
Quarterly Net Profit at Rs. 170.22 crore in September 2020 up 46.29% from Rs. 116.36 crore in September 2019. EBITDA stands at Rs. 279.10 crore in September 2020 up 46.23% from Rs. 190.86 crore in September 2019.
Ajanta Pharma EPS has increased to Rs. 19.51 in September 2020 from Rs. 13.34 in September 2019.
Also Check:- Latest Share Buyback 2020
Upcoming Buyback 2020
INVESTOR ACADEMY ? is now on Telegram. Click here to join our channel and stay updated with the Latest Dividends, IPOs news and stock market updates.
Ajanta Pharma Buyback Important Dates
In this section we have covered all important dates related to “Ajanta Pharma Buyback Date”. Dates are updated as they are announced. The most noted dates are Ajanta Pharma record date and Ajanta Pharma buyback open and close dates, which one should use to participate in buyback.
| Buyback Activity | Date |
|---|---|
| Board Meeting for Ajanta Pharma Buyback proposal | 03.11.2020 |
| Ajanta Pharma Buyback Approval date | 03.11.2020 |
| Public Announcement of Ajanta Pharma Buyback | 03.11.2020 |
| Ajanta Pharma Buyback Record Date | 13.11.2020 |
| Ajanta Pharma Buyback opens on/Buyback Opening Date | 03.12.2020 |
| Ajanta Pharma Buyback closes on/Buyback Closing Date | 16.12.2020 |
| Cut-off date to receive completed tender forms by Registrar | 18.12.2020 |
| Cut-off date for verification by the Registrar | 22.12.2020 |
| Cut-off date to inform Stock Exchange on acceptance or non-acceptance of tendered Equity Shares by Registrar | 23.12.2020 |
| Last date of settlement of bids on the stock exchange | 24.12.2020 |
| Last date to return unaccepted shares by Registrar | 24.12.2020 |
| Last date of extinguishment of Equity Shares | 30.12.2020 |
| UPCOMING IPO | Best Stocks to buy | UPCOMING DIVIDEND |
| UPCOMING NCD | UPCOMING BONUS | UPCOMING Buybacks of Shares |
Ajanta Pharma Share Holding Pattern as of SEP 2020
Stock Holding table gives a clear picture on retail investor holdings of Ajanta Pharma shares which helps investor to decide on participating in buyback offer. The less number of retail holdings means higher chance of acceptance in Ajanta Pharma buyback under retail category which is equal to higher profit.
| Shareholding Pattern – Ajanta Pharma Ltd. | ||
| Holder’s Name | No of Shares | % Share Holding |
| No Of Shares | 8,72,66,770 | 100% |
| Promoters | 6,15,28,601 | 70.51% |
| Foreign Institutions | 67,17,114 | 7.71% |
| N Banks Mutual Funds | 8669400 | 9.93% |
| Central Govt | 655215 | 0.75% |
| Others | 892897 | 1.02% |
| General Public | 7475036 | 8.57% |
| Financial Institutions | 1309183 | 1.5% |
Ajanta Pharma Buyback Record Date
Tentative Record Date To Participate In Ajanta Pharma Buyback
The company has fixed 13 November, 2020 as the record date for the purpose of ascertaining the eligibility of shareholders for buyback of equity shares.
Ajanta Pharma Buyback Acceptance Ratio
Profit from the buyback on the bases of acceptance Ratio:
Buy 108 Shares at CMP of Rs.1620 ( 2,00,000/1850=108)
| Acceptance Ratio | 33% | 50% | 75% | 100% |
| Amount Invested in Buyback | 199800 | 199800 | 199800 | 199800 |
| No. of Shares buyback | 36 | 54 | 81 | 108 |
| Buyback Profit | 8197 | 12420 | 18630 | 24840 |
| Profit | 4.10% | 6.22% | 9.32% | 12.43% |
How to Apply for Ajanta Pharma Buyback?
Now if you are wondering ‘how do I apply for a buyback?’ we’ve got you covered. When it comes to share-buyback schemes, the capital market regulator has compulsorily reserved a buyback portion of 15% for retail investors who possess in-hold shares in a company worth upto ₹2 lakhs.
This percentage is also taking into account the scrip’s market value as seen on the record date of the buyback offer. During the application process of share buyback, you will be given a tender form by the company.
This form is where you enter the number of shares of that company that you wish to tender. There is a ratio of acceptance attached to the tender form which signifies how likely the company is to accept your request for share buybacks.
Different companies have different ratios for share buybacks. Here is what you can expect in a typical tender form given by a company. There are normally three fields as follows:
- The number of shares you hold from the said company as on the record date
- The number of shares that fit the eligibility criteria for buybacks
- The number of shares that one is applying for a buyback.
Apply Ajanta Pharma buyback from Zerodha
Here is complete method from Zerodha You can apply for Buybacks on Console> Portfolio> Corporate action order window
- Hover your mouse on the stock and select ‘Options’ and click on ‘Place order’
- Enter the number of shares you want to tender and click on ‘Submit’
- Buyback/Takeover/Delisting orders are collected until 6:00 PM, one trading day prior to the offer end date. Ensure to hold sufficient quantities in your demat account before closure of the offer end date. (Do not sell the shares after placing the order). Only shareholders who hold the shares as on the record date will be eligible for the corporate action.
Latest & Upcoming Buybacks 2020
| TCS Buyback | NMDC Buyback | HPCL Buyback |
| WIPRO Buyback | NTPC Buyback | GAIL Buyback |
| Buyback | Buyback | IIFL Securities Buyback |
About Ajanta Pharma
Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages.
Committed to ‘Serve Health Care Needs Worldwide’, we produce a comprehensive range of specialty products targeting different therapeutic segments for treatment of patients, customized to each market we are present in.
We clearly understand our customer’s needs and use cutting edge technology to present innovative solutions. Our business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales.
Ajanta Pharma Financial
Salient financial parameters:
| Particulars (Cr) | Mar-15 | Mar-16 | Mar-17 | Mar-18 | Mar-19 | Mar-20 |
| Sales | 1,474 | 1,749 | 1,983 | 2,126 | 2,055 | 2,588 |
| Expenses | 969 | 1,161 | 1,292 | 1,467 | 1,489 | 1,904 |
| Operating Profit | 504 | 589 | 691 | 658 | 567 | 683 |
| OPM % | 34% | 34% | 35% | 31% | 28% | 26% |
| Other Income | 9 | 20 | 20 | 24 | 21 | 88 |
| Interest | 6 | 5 | 1 | 0 | 1 | 12 |
| Depreciation | 52 | 44 | 61 | 60 | 72 | 96 |
| Profit before tax | 456 | 559 | 648 | 623 | 514 | 664 |
| Tax % | 32% | 26% | 22% | 25% | 25% | 30% |
| Net Profit | 310 | 416 | 507 | 469 | 387 | 468 |
| EPS in Rs | 35.25 | 47.23 | 57.59 | 53.25 | 44.35 | 53.6 |
| Dividend Payout % | 17% | 17% | 23% | 0% | 20% | 24% |
Source: Screener.in
Ajanta Pharma Limited – Registrar to the Buyback
| LINK INTIME INDIA PRIVATE LIMITED C-101, 1st Floor, 247 Park, L.B.S Marg, Vikhroli (West), Mumbai 400 083 Maharashtra, India Contact Person: Mr. Sumeet Deshpande Tel: +91 22 4918 6200 Fax: +91 22 4918 6195 E-mail: ajantapharma.buyback@linkintime.co.in Website: www.linkintime.co.in SEBI Registration Number: INR000004058; Validity Period: Permanent CIN: U67190MH1999PTC118368 |
Ajanta Pharma Limited Contact Details
| Company Contact Details |
| AJANTA PHARMA LIMITED Registered & Corporate Office: ‘Ajanta House’, 98 Govt Industrial Area, Charkop, Kandivli (West), Mumbai – 400 067, Maharashtra, India CIN: L24230MH1979PLC022059 Contact Person: Mr. Gaurang Shah, Company Secretary Tel: +91 22 6606 1000 | Fax: +91 22 6606 1200 Email: investorgrievance@ajantapharma.com | Website: www.ajantapharma.com |
***Related Queries***
Ajanta Pharma Buyback Important dates – Record Date, Buyback Start and End date. Buyback Details – Buyback Price, Buyback Offer Size, Buyback Number of Shares, Retail Investors limit. What is the record date for Ajanta Pharma buyback?
How can I apply in Ajanta Pharma Buyback offer? Ajanta share buyback, Ajanta Pharma share buyback news, Ajanta Pharma share latest news, Ajanta Pharma share news, Ajanta Pharma share price today, Ajanta Pharma share price, Ajanta Pharma stock latest, Ajanta Pharma share target, Ajanta Pharma share latest target , Ajanta Pharma November 4 , Ajanta Pharma buyback, Ajanta Pharma buyback date, Ajanta Pharma buyback important date, Ajanta Pharma buyback, Ajanta Pharma share news.
Ajanta Pharma Buyback 2020 FAQs:
Ajanta Pharma buyback 2020 record date is Nov 13, 2020.
Ajanta Pharma buyback 2020 announcement date is Nov 3, 2020.
The company has fixed the price at ₹1,850 a share
As per the Ajanta Pharma record date you need to have Ajanta Pharma shares in your demat account. You can participate in buyback after having the stock in your account.
The Record Date for Ajanta Pharma Buyback offer: The company has fixed 13 November, 2020 as the record date for the purpose of ascertaining the eligibility of shareholders for buyback of equity shares.
You can earn a premium of 20% from current market price.
Its all depend on acceptance ratio which usually announce with Letter of Offer. The percentage of proportionate acceptance varies from company to company. This percentage can be also 100% which means that company buys all of your shares.
Steps to participate in Ajanta Pharma buyback:
On Record date (13.11.2020) you must have share of Ajanta Pharma in your demat account. Depositing of share in your DP account usually take T+2 days, so you need to plan your buying accordingly.
After that company announces buyback open and close window, so you need to tender your share in buyback process. You can do this online or contact your broker to tender your share in buyback, so he can place a request on your behalf.
Next step is with registrar – depend on buyback acceptance ratio, your shares will be sold in buyback process and fund will directly debited in your bank account. Any rejected share will be revert in your demat account which you can sell in open market or hold for long term gain.
Share holders who hold less than 2 lakh worth of shares are consider in Retail Category. All others will consider in General Category. Last trading price on record date will be used to calculate the eligibility criteria.
Buyback opening date for Ajanta Pharma: (Coming Soon) Buyback closing date for Ajanta Pharma: (Coming Soon) This is the window when you need to submit your application for proposal for share buyback.
As this is a buyback tender offer, shares are accepted in proportionate basis. Proportionate acceptance / rejection will be returned back to the eligible shareholders directly by the Registrar on or before (Coming Soon).